Dr. MartensCHIX:DOCSL +2.28%52 EBIT per Share is £0.06 as of Mar. 2026. GuruFocus rates CHIX:DOCSL with a GF Score™ of 52/100 and a GF Value™ of £0.72 (Fairly Valued). The stock has 3 warning signs investors should review. Among 823 Manufacturing - Apparel & Accessories companies, Dr. Martens ranks worse than 86.63% on this metric.
Dr. Martens's EBIT per Share for the
six
months ended in Mar. 2026 was £0.06.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was £0.06.
During the past 12 months, the average EBIT per Share Growth Rate of Dr. Martens was 34.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -31.30% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -26.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Dr. Martens's EBIT per Share or its related term are showing as below:
CHIX:DOCSl'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -41.1 Med: -2.2 Max: 67.5
Current: -31.3
During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Dr. Martens was 67.50% per year. The lowest was -41.10% per year. And the median was -2.20% per year.
CHIX:DOCSl's 3-Year EBIT Growth Rate is ranked worse than 86.63% of 823
companies
in the Manufacturing - Apparel & Accessories industry
Industry Median: 0.8
vs CHIX:DOCSl: -31.30
Dr. Martens's EBIT for the
six
months ended in Mar. 2026 was £56.8 Mil.
Dr. Martens (CHIX:DOCSl) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Dr. Martens EBIT per Share Related Terms
Dr. Martens EBIT per Share Historical Data
* Premium members only.
The historical data trend for Dr. Martens's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr. Martens (CHIX:DOCSL) has a EBIT per Share of £0.06 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Dr. Martens and its competitors. According to the industry distribution chart, Dr. Martens ranks #713 out of 823 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 86.6%.
Is Dr. Martens' EBIT per Share too high?
Dr. Martens' current EBIT per Share is £0.06. Based on the distribution chart, Dr. Martens ranks #713 out of 823 companies in the Manufacturing - Apparel & Accessories industry, which is in the bottom quartile relative to peers. Overall, Dr. Martens has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' EBIT per Share compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Dr. Martens ranks #713 out of 823 companies for EBIT per Share. This places Dr. Martens in the lower half of its industry. The industry median EBIT per Share is 0.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Manufacturing - Apparel & Accessories company?
The median EBIT per Share among Manufacturing - Apparel & Accessories companies is 0.80, based on 823 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Dr. Martens and its competitors. For the Manufacturing - Apparel & Accessories industry, the median EBIT per Share is 0.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr. Martens's current EBIT per Share is £0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (CHIX:DOCSL) is currently considered Fairly Valued. The stock's GF Value™ is £0.72, compared to a current price of £0.72 — trading 0.3% below its estimated fair value. The current EBIT per Share is £0.06. Dr. Martens' overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Dr. Martens (CHIX:DOCSL), the current EBIT per Share is £0.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Martens (CHIX:DOCSL) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Martens stock appears to be undervalued.
The current stock price of £0.72 is trading 0.3% below its estimated GF Value™ of £0.72.
GuruFocus considers Dr. Martens to be Fairly Valued.
Key valuation signals for CHIX:DOCSL:
EBIT per Share: £0.06
GF Value™: £0.72 vs. price of £0.72 (0.3% below fair value)
No single metric tells the full story. See the CHIX:DOCSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
52GF Score
Get the complete analysis for CHIX:DOCSL
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:DOCSL has been successfully added to your 
